However, there were no statistically significant associations between the status of ZKSCAN3 expression in bladder tumors and patient gender (male vs. female tumors), tumor grade [papillary urothelial neoplasm of low malignant potential (PUMLMP) + low-grade urothelial carcinoma vs. high-grade urothelial carcinoma], pT stage (non-muscle-invasive vs. muscle-invasive), or lymph node metastasis (pN0 vs. pN+). This evidence concerns the gene ZKSCAN3 and metastatic malignant neoplasm in the lymph nodes.